# Cerebral Palsy Risk by Combined Apgar Score and Umbilical Cord Blood pH Levels

**Authors:** Mette Vestergård Pedersen, Morten Søndergaard Lindhard, Dag Moster, Rolv Terje Lie, Tine Brink Henriksen

PMC · DOI: 10.1001/jamanetworkopen.2025.59359 · JAMA Network Open · 2026-02-18

## TL;DR

Low Apgar scores and low umbilical cord blood pH together strongly increase the risk of cerebral palsy in newborns.

## Contribution

This study shows that combining clinical and biochemical measures improves the prediction of cerebral palsy risk.

## Key findings

- Combined low Apgar score and pH <7.00 had a 159-fold higher risk of CP compared to normal measures.
- Severe CP was 4.8 times more common in children with abnormal Apgar and pH than those with normal measures.
- Low pH alone had a 6-fold higher CP risk than normal pH with normal Apgar.

## Abstract

This cohort study investigates the association of combined Apgar score and umbilical cord blood pH measures of perinatal hypoxia with cerebral palsy among singleton births.

Is perinatal hypoxia assessed by the combination of clinical and biochemical measures (Apgar score and umbilical cord blood pH) associated with cerebral palsy?

In this cohort study of 825 159 singleton newborns (≥35 gestational weeks), the combination of low Apgar score and low umbilical cord blood pH was associated with an increased risk of cerebral palsy, substantially higher than when 1 measure was abnormal.

This study found that cerebral palsy risk was highest when both clinical and biochemical measures were abnormal.

Perinatal hypoxia is an important cause of cerebral palsy (CP). Although criteria for relevant perinatal hypoxia require both clinical and biochemical abnormalities, such as low Apgar score and low umbilical cord blood pH, most observational studies have considered only 1 of these measures.

To investigate the association of perinatal hypoxia assessed by Apgar score combined with umbilical cord blood pH with CP.

This registry-based cohort study was conducted nationwide in Denmark with follow-up until December 31, 2022. Analyses were performed from October 2024 to May 2025. All singleton newborns with a gestational age of 35 weeks or older without major malformations between January 1, 2004, and December 31, 2018, with at least 1 year of follow-up were included.

Combinations of 5-minute Apgar score category (0-3, 4-6, and 7-10) and umbilical cord blood pH category (<7.00, 7.00-7.09, 7.10-7.19, and ≥7.20). Newborns with an Apgar score of 7 to 10 combined with a pH level of 7.20 or greater were considered as a reference group.

Any diagnosis of CP. Associations between Apgar score combined with pH level and CP were estimated with multivariable log-binomial regression. Severe CP was defined as Gross Motor Function Classification System level IV to V.

The cohort included 825 159 newborns (422 409 male [51.2%]; 432 398 born at 39-40 weeks of gestation among 822 913 with gestational age data [52.5%]). Among 145 children with the lowest Apgar score (0-3) combined with the lowest pH level (<7.00), 22 individuals (15.2%) were diagnosed with CP, corresponding to an adjusted relative risk (aRR) of 159.0 (95% CI, 104.0-243.0). In 2463 children with a normal Apgar score (7-10) but the lowest pH level (<7.00), 14 individuals (0.6%) were diagnosed with CP (aRR, 6.1; 95% CI, 3.7-10.0). Among 388 children with the lowest Apgar score (0-3) combined with a normal pH level (≥7.20), 8 individuals (2.1%) were diagnosed with CP (aRR, 22.0; 95% CI, 11.0-44.0). Severe CP was observed in 31 of 63 children (49.2%) with CP and an Apgar score of 0 to 6 combined with a pH level less than 7.20 compared with 39 of 385 children (10.1%) with CP and a normal Apgar score and pH level (P < .001).

In this study, perinatal hypoxia assessed by clinical and biochemical measures was associated with CP risk, with a higher risk when both measures were abnormal. These findings may guide future identification for follow-up of children with perinatal hypoxia.

## Linked entities

- **Diseases:** cerebral palsy (MONDO:0006497)

## Full-text entities

- **Diseases:** perinatal (MESH:D066087), brain injury (MESH:D001930), brain (MESH:D001927), death (MESH:D003643), posture (MESH:D054972), TH (MESH:D007035), Asphyxia (MESH:D001237), acidosis (MESH:D000138), infection (MESH:D007239), malformations of the heart, respiratory system, nervous system, or gastrointestinal tract (MESH:D015619), Neonatal Encephalopathy (MESH:D007232), neuronal (MESH:D009410), motor disabilities (MESH:D009069), hypoxic ischemic encephalopathy (MESH:D020925), developmental delay (MESH:D002658), malformations (MESH:C564254), neurologic malformations (MESH:D009421), CP (MESH:D002547), chromosomal abnormalities (MESH:D002869), disability of motor function (MESH:D003291), hypoxic (MESH:D002534), hypoxia (MESH:D000860)
- **Chemicals:** oxygen (MESH:D010100)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917687/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917687/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917687/full.md

---
Source: https://tomesphere.com/paper/PMC12917687